Concepedia

Hengliang Shi

HS

Statistics

Publications

34

Citations

883

H-Index

17

Active since

2009

Affiliations

Xuzhou Medical College(Current)

Affiliated Hospital of Xuzhou Medical College

Northeast Normal University

Nantong University

Universitätsklinikum Aachen

Hengliang Shi is an author at Xuzhou Medical College specializing in oncology, molecular oncology, and cancer cell signaling.

ORCID

Publications per year

2009–2023

34

Publications

34

Hydrophobic poly (amino acid) modified PEI mediated delivery of rev-casp-3 for cancer therapy

Chunling Fu, Lin Lin, Hengliang Shi et al. · Biomaterials · 2012 · 77 citations

, , +11

Carbon nitride-based nanocaptor: An intelligent nanosystem with metal ions chelating effect for enhanced magnetic targeting phototherapy of Alzheimer's disease

Ling Gong, Xing Zhang, Kezhen Ge et al. · Biomaterials · 2020 · 71 citations

, , +14

The atypical protein kinase RIOK3 contributes to glioma cell proliferation/survival, migration/invasion and the AKT/mTOR signaling pathway

Tong Zhang, Daofei Ji, Peng Wang et al. · Cancer Letters · 2017 · 58 citations

, , +14

Nanobodies - the new concept in antibody engineering

Khalissa Deffar, Hengliang Shi, Liang Li et al. · AFRICAN JOURNAL OF BIOTECHNOLOGY · 2009 · 47 citations · Full text

, , +17

Loss of SH3GL2 promotes the migration and invasion behaviours of glioblastoma cells through activating the STAT3/MMP2 signalling

Yufu Zhu, Xiang Zhang, Lei Wang et al. · Journal of Cellular and Molecular Medicine · 2017 · 38 citations · Full text

, , +15

1–5 of 34